Coiante Scott M 4
4 · Aprea Therapeutics, Inc. · Filed Oct 7, 2019
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to Buy)
2019-10-07+150,824→ 150,824 totalExercise: $15.00Exp: 2029-10-02→ Common Stock (150,824 underlying) - Purchase
Common Stock
2019-10-07$15.00/sh+2,500$37,500→ 2,500 total
Footnotes (1)
- [F1]Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.